Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lymphoma

Brain Tumor Pathology · Published 2024-08-26 · DOI 10.1007/s10014-024-00488-7

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s10014-024-00488-7

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2024

Related articles

Preface for Brain Tumor Pathology vol.41 issue 2 · Brain Tumor Pathology · 2024 · Same journal
Targeting TGF-β signaling in glioblastoma: therapeutic implications and novel drug development strategies · Brain Tumor Pathology · 2025 · Same journal
Molecular analysis of a gliosarcoma with distinct oligodendroglioma and sarcomatous components (“Oligosarcoma”) · Brain Tumor Pathology · 2026 · Same journal
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy · Brain Tumor Pathology · 2024 · Same journal
Primary sellar glomus tumor with BRAF K601E mutation: an aggressive tumor of uncertain malignant potential · Brain Tumor Pathology · 2025 · Same journal
A rare case of supratentorial ependymosarcoma harboring ZFTA::RELA fusion · Brain Tumor Pathology · 2025 · Same journal
Biphasic high-grade cerebellar glioma with epithelial-like components: challenges in integrated diagnosis imposed by limited sampling · Brain Tumor Pathology · 2026 · Same journal
Diffuse midline glioma, H3K27-altered: a rare presentation with gliomatosis cerebri growth pattern and progression toward midline · Brain Tumor Pathology · 2025 · Same journal
Astroblastoma with MN1::BEND2 in an elderly patient: A case report and review of the literature · Brain Tumor Pathology · 2024 · Same journal
Comparative molecular profiles of distinct tumor components in recurrent tentorial meningioma after stereotactic radiosurgery: a case report implicating acquired aggressive alterations associated with WHO grade progression · Brain Tumor Pathology · 2026 · Same journal